Biotheranostics Announces Inclusion of Breast Cancer Index in the National Comprehensive Cancer Network (NCCN) Breast Cancer Guidelines for Prediction of Benefit from Extended Endocrine Therapy


Translating Science into Solutions for Individualized Patient Care

Biotheranostics is a commercial stage molecular diagnostics company focused on cancer. We have two high-value proprietary and uniquely differentiated tests on the market, focused on critical areas of unmet medical needs. We are entering a rapid-growth phase with increasingly diversified growth drivers.

Contact Biotheranostics for more information on partnering with us:

Client Services: (877) 886 6739

Fax: (858) 587 5874